Reimagining Diabetes Quality Measurement to Advance Quality Care

Bodenheimer T , Sinsky C . From triple aim to quadruple aim: care of the patient requires care of the provider. Ann Fam Med, 2014; 12:573–576.

Berwick DM , Nolan TW , Wittington J . The triple aim: care, health, cost. Health Aff (Millbank), 2008; 27:759–769.

U.S. Food and Drug Administration. Surrogate Endpoint Resources for Drug and Biologic Development. 2018. https://www.fda.gov/drugs/development-resources/surrogate-endpoint-resources-drug-and-biologic-development Accessed February 11, 2023 .

Rodriguez-Gutierrez R , McCoy RG . Measuring what matters in diabetes. JAMA, 2019; 321:1856–1866.

Jiang DH , O'Connor PJ , Huguet N , Golden SH , McCoy RG . Modernizing diabetes care quality measures. Health Aff (Millbank), 2022; 41:955–962.

Wang L , Li X , Wang Z , et al. Trends in prevalence of diabetes and control of risk factors in diabetes among US adults, 1999–2018. JAMA, 2021; 326:704–716.

Haw JS , Shah M , Turbow S , Egeolu M , Umpierrez G . Diabetes complications in racial and ethnic minority populations in the USA. Curr Diabetes Rep, 2021; 21:2.

Mansour O , Golden SH , Yeh HC . Disparities in mortality among adults with and without diabetes by sex and race. J Diabetes Compl, 2020; 34:107496.

Institute of Medicine. Crossing the quality chasm: a new health system for the 21st century. Washington, DC: National Academies Press, 2001.

Jiang D , McCoy R , Hill Golden S , Huguet N , O'Connor P . Modernizing diabetes care quality measures. Health Affairs, 2022; 41:955–962.

Shrank WH , Rogstad TL , Parekh N . Waste in the US health care system: estimated costs and potential for savings. JAMA, 2019; 322:1501–1509.

Hill-Briggs F , Adler NE , Berkowitz SA , et al. Social determinants of health and diabetes: a scientific review. Diabetes Care, 2021; 44:258–279.